James E. Fickenscher
2016 - Zynerba Pharmaceuticals
In 2016, James E. Fickenscher earned a total compensation of $1.3M as Chief Financial Officer and Vice President, Corporate Development at Zynerba Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $151,060 |
|---|---|
| Option Awards | $1,042,285 |
| Salary | $97,000 |
| Other | $12,033 |
| Total | $1,302,378 |
Fickenscher received $1M in option awards, accounting for 80% of the total pay in 2016.
Fickenscher also received $151.1K in non-equity incentive plan, $97K in salary and $12K in other compensation.
Rankings
In 2016, James E. Fickenscher's compensation ranked 6,949th out of 14,075 executives tracked by ExecPay. In other words, Fickenscher earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,949 out of 14,075 | 51st |
Division Manufacturing | 2,610 out of 5,489 | 53rd |
Major group Chemicals And Allied Products | 851 out of 1,895 | 55th |
Industry group Drugs | 654 out of 1,538 | 58th |
Industry Pharmaceutical Preparations | 519 out of 1,176 | 56th |
Source: SEC filing on April 23, 2018.
Fickenscher's colleagues
We found two more compensation records of executives who worked with James E. Fickenscher at Zynerba Pharmaceuticals in 2016.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019